Loefflers syndrome differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
(Undo revision 1568157 by Soroush Seifirad (talk))
Tag: Undo
Line 38: Line 38:
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3
! style="background: #4479BA; color: #FFFFFF; text-align: center;" |Imaging 3
|-
|-
| rowspan="5" |Helminthic  
| rowspan="5" |Helminthic and fungal infection-related eosinophilic lung diseases
and
 
fungal  
 
infection-
 
related eosinophilic lung  
 
diseases
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Transpulmonary passage of larvae (Loffler's syndrome)
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Transpulmonary passage of larvae (Loffler's syndrome)
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 180: Line 171:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| colspan="2" |Eosinophilic  
| colspan="2" |Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)
granulomatosis
 
with  
 
polyangiitis  
 
(Churg-Strauss)
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 204: Line 188:
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
|-
| colspan="2" |Drug  
| colspan="2" |Drug- and toxin-induced eosinophilic lung diseases
and  
 
toxin-
 
induced  
 
eosinophilic  
 
lung  
 
diseases
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |

Revision as of 23:14, 14 May 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Soroush Seifirad, M.D.[2]

Overview

Loeffler syndrome must be differentiated from other diseases that cause pulmonary eosinophilia, such as Churg-Strauss, drug and toxin-induced eosinophilic lung diseases, other helminthic and fungal infection related eosinophilic lung diseases, and nonhelminthic infections such as Coccidioidomycosis, and Mycobacterium tuberculosis, .

Differentiating Loeffler syndrome from other pulmonary eosinophilia syndromes on the basis of etiology.

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging Histopathology
Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Increased Eosinophil count

(High)

Increased Eosinophil count

(Mild to moderate)

Lab 3 Imaging 1 Imaging 2 Imaging 3
Helminthic and fungal infection-related eosinophilic lung diseases Transpulmonary passage of larvae (Loffler's syndrome)
  • Ascaris lumbricoides
  • Hookworms such as:
  • Ancylostoma duodenale
  • Necator americanus)
  • Strongyloides stercoralis
Tropical pulmonary eosinophilia 40 to 70 percent
  • Wuchereria bancrofti
  • Brugia malayi
Allergic bronchopulmonary aspergillosis *
Heavy hematogenous seeding with helminths
  • Trichinellosis
  • Disseminated strongyloidiasis
  • Cutaneous and visceral larva migrans
  • Schistosomiasis
Pulmonary parenchymal invasion
  • Helminths such as paragonimiasis
Nonhelminthic infections Coccidioidomycosis
Mycobacterium tuberculosis
Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) *
Drug- and toxin-induced eosinophilic lung diseases *
  • Nonsteroidal antiinflammatory drugs
  • Phenytoin
  • L-tryptophan
  • Antibiotics (nitrofurantoin, minocycline, sulfonamides, ampicillin, daptomycin)
Acute eosinophilic pneumonia
Chronic eosinophilic pneumonia ≥40 percent
Idiopathic acute eosinophilic pneumonia ≥25 percent
Diseases Symptom 1 Symptom 2 Symptom 3 Physical exam 1 Physical exam 2 Physical exam 3 Increased Eosinophil count

(High)

Increased Eosinophil count

(Mild to moderate)

Lab 3 Imaging 1 Imaging 2 Imaging 3 Histopathology Gold standard Additional findings
Sarcoidosis *
Pulmonary Langerhans cell histiocytosis (Histiocytosis X) *
Idiopathic pulmonary fibrosis <10 percent
Differential Diagnosis 7

References

Template:WH Template:WS